Group 1 - Shandong Hanfang Pharmaceutical Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, with ZTSC as the sole sponsor [1] - The company specializes in the production, sales, and research of traditional Chinese medicine products, focusing on the treatment of skin and mucosal diseases [1] - According to Frost & Sullivan, the compound Huangbai liquid ointment ranks fourth in the Chinese external traditional Chinese medicine market, holding a market share of 1.1% based on projected sales revenue for 2024 [1] Group 2 - The company aims to integrate traditional Chinese medicine wisdom with modern pharmaceutical science [1] - The listing will involve H shares, with specific details on pricing and associated fees outlined in the application [2]
新股消息 | 汉方制药递表港交所
智通财经网·2026-02-25 12:18